Literature DB >> 12485604

Chronic liver and renal diseases differently affect structure of human serum albumin.

Andrei I Ivanov1, Elena A Korolenko, Elena V Korolik, Stanislav P Firsov, Rostislav G Zhbankov, Mariusz K Marchewka, Henryk Ratajczak.   

Abstract

Human serum albumin (HSA) binding with endogenous metabolites and drugs is substantially decreased in chronic renal and liver diseases. To test the hypothesis that the decreased binding ability is caused by conformational changes of the protein, we analyzed infrared and Raman spectra of HSA isolated from healthy donors and patients with chronic uremia and liver cirrhosis. Uremia did not affect the secondary structure of HSA but modified the environment of its Asp/Glu residues. Liver cirrhosis increased the amount of extended and beta-structures, modified the environment of Asp/Glu and Tyr side chains, and changed the configuration of disulfide bridges in albumin molecules. The conformational changes of "cirrhotic" albumin were not caused by reversibly bound ligands and resembled a partial unfolding of the protein induced by adsorption on the charcoal surface. The dramatic structural alterations of HSA in liver cirrhosis may be caused by its oxidative modification and might underlie the decreased binding ability and changed body distribution of albumin.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12485604     DOI: 10.1016/s0003-9861(02)00533-7

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  7 in total

1.  Albumin-based nanoparticles as magnetic resonance contrast agents: I. Concept, first syntheses and characterisation.

Authors:  M M Stollenwerk; I Pashkunova-Martic; C Kremser; H Talasz; G C Thurner; A A Abdelmoez; E A Wallnöfer; A Helbok; E Neuhauser; N Klammsteiner; L Klimaschewski; E von Guggenberg; E Fröhlich; B Keppler; W Jaschke; P Debbage
Journal:  Histochem Cell Biol       Date:  2010-02-20       Impact factor: 4.304

2.  Ischemia-modified albumin levels in overt and subclinical hypothyroidism.

Authors:  S V Reddy; M M Suchitra; V Pradeep; S Alok; V Suresh; A R Bitla; P V L N Srinivasa Rao
Journal:  J Endocrinol Invest       Date:  2015-04-11       Impact factor: 4.256

3.  Structural changes of human serum albumin in response to a low concentration of heavy ions.

Authors:  Anushree Saha; Vladislav V Yakovlev
Journal:  J Biophotonics       Date:  2010-10       Impact factor: 3.207

4.  The Role of Ischemia Modified Albumin as a Biomarker in Patients with Chronic Liver Disease.

Authors:  Prashanth Ashok Kumar; Kavitha Subramanian
Journal:  J Clin Diagn Res       Date:  2016-03-01

5.  Elimination of endogenous toxin, creatinine from blood plasma depends on albumin conformation: site specific uremic toxicity & impaired drug binding.

Authors:  Ankita Varshney; Mohd Rehan; Naidu Subbarao; Gulam Rabbani; Rizwan Hasan Khan
Journal:  PLoS One       Date:  2011-02-28       Impact factor: 3.240

6.  Thiol/disulfide homeostasis and ischemia modified albumin levels in autoimmune gastritis and their relations with gastric emptying

Authors:  Emra Asfuroğlu Kalkan; Serap Boz; Özcan Erel; Salim Neşelioğlu; Çağdaş Kalkan; Irfan Soykan
Journal:  Turk J Med Sci       Date:  2020-02-13       Impact factor: 0.973

7.  The Spectroscopy Study of the Binding of an Active Ingredient of Dioscorea Species with Bovine Serum Albumin with or without Co(2+) or Zn(2+).

Authors:  He-Dong Bian; Xia-Lian Peng; Fu-Ping Huang; Di Yao; Qing Yu; Hong Liang
Journal:  Evid Based Complement Alternat Med       Date:  2014-06-04       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.